Document is current

Any future updates will be listed below

200 TGFβ-armoring boosts potency and persistence of engineered TCR T cells, unlocking superior efficacy against HPV-positive solid tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.200

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark